Expert Statements

Expert Statement: Ludwig de Mot, EuroAPI

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Expert Statement: Russel Miller, Enzene

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Expert Statement: Frank Wegener, ESIM Chemicals

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Expert Statement: David McErlane and Aris Gennadios, Catalent

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Expert Statement: Neil Jones, Aenova

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Expert Statement: Gavin Murdoch, Abzena

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Flow Chemistry

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Andreas Woschek, Executive Vice President Chemicals, Helm

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Patrick Barthels, CSO and Hartmut Kunz, CFO, Oqema

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Gerd Bergmann, Chairman of the Managing Board, Nordmann

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Thomas Dassler, Managing Director, Häffner

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Christopher Erbslöh, Managing Director, C.H. Erbslöh

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Neville Prior, Group Chairman, Cornelius Group

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Felix Thalmann, CEO, Büfa Group

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Robert Späth, Managing Partner, CSC Jäklechemie

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Hans Joachim Müller, Group CEO, Azelis

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Christian Kohlpaintner, CEO, Brenntag

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Expert Statement: Thorsten Harke President, Harke Group

CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.

Both Positive and Negative Effects

Ensuring Better Efficiency and Consistency

Earning a Large Chunk of the Cake

Pharma R&D Productivity Needs Improvement

Confidentiality is a Potential Pitfall

Consolidation is here to Stay

Changes in Portfolios and Pipelines are Likely

Setting High Standards

A Partner to Relieve the Strain